13F 机构持仓

Affinity Asset Advisors, LLC

NEW YORK NY · SEC CIK 0001773195

2026Q22026Q1 更早 9 个季度 🔒
$22.12亿2026Q2 申报市值
113持仓数
39.4%前十大占比 · 第一大 6.0%
25 / 18新建仓 / 清仓
申报市值走势$22.12亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

ROIV 6.0%
APOGEE THERAPE 5.9%
SYRE 5.1%
XENE 4.4%
ERAS 4.3%
INSM 3.1%
PRAX 2.8%
ALKS 2.7%
ORKA 2.5%
ANAB 2.5%

2026Q2 买入最多 按季末市值估算

TRAX 新建仓+$4,088.41万
ROIV 加仓+$3,362.05万
AVTX 加仓+$2,881.33万
RVMD 加仓+$2,809.20万
INSM 加仓+$1,812.54万

2026Q2 卖出最多 按季末市值估算

CENTESSA PHARMAC 清仓-$5,560.80万
ARCELLX INC 清仓-$4,165.26万
APOGEE THERAPEUT 减仓-$3,954.37万
TEVA PHARMACEUTI 减仓-$3,476.09万
TERNS PHARMACEUT 清仓-$2,966.19万

2026Q2 持仓明细 点表头排序 · 每页 100 行

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
ANRO ALTO NEUROSCIENCE INC $2,243.15万1.01%850,000 350,00070.0% $923.65万 加仓
NRIX NURIX THERAPEUTICS INC $2,347.45万1.06%967,620 00.0% — 不变
LLY ELI LILLY & CO 看涨期权 $2,398.86万1.08%20,000 20,000— $2,398.86万 新建仓
— FORTE BIOSCIENCES INC $2,433.96万1.10%1,145,391 133,50113.2% $283.69万 加仓
ELVN ENLIVEN THERAPEUTICS INC $2,537.50万1.15%500,000 -86,904-14.8% -$441.04万 减仓
BLTE BELITE BIO INC $2,540.75万1.15%165,000 100,000153.8% $1,539.85万 加仓
CLDX CELLDEX THERAPEUTICS INC NEW $2,604.70万1.18%700,000 200,00040.0% $744.20万 加仓
LXEO LEXEO THERAPEUTICS INC $2,703.44万1.22%5,807,611 757,40015.0% $352.57万 加仓
OVID OVID THERAPEUTICS INC $2,728.89万1.23%10,144,562 -491,756-4.6% -$132.28万 减仓
ARKG ARK ETF TR 看涨期权 $3,154.50万1.43%750,000 750,000— $3,154.50万 新建仓
MRNA MODERNA INC 看涨期权 $3,326.43万1.50%475,000 -325,000-40.6% -$2,275.97万 减仓
TRVI TREVI THERAPEUTICS INC $3,357.32万1.52%1,800,172 -200,000-10.0% -$373.00万 减仓
— NUVALENT INC $3,396.25万1.54%275,000 -25,000-8.3% -$308.75万 减仓
MRNA MODERNA INC 看跌期权 $3,501.50万1.58%500,000 500,000— $3,501.50万 新建仓
STRO SUTRO BIOPHARMA INC $3,892.66万1.76%1,172,487 102,9689.6% $341.85万 加仓
DNTH DIANTHUS THERAPEUTICS INC $3,899.20万1.76%400,000 50,00014.3% $487.40万 加仓
TRAX FIRST TRACKS BIOTHERAPEUTICS $4,088.41万1.85%2,032,012 2,032,012— $4,088.41万 新建仓
ABVX ABIVAX SA $4,397.58万1.99%330,000 -75,000-18.5% -$999.45万 减仓
RVMD REVOLUTION MEDICINES INC $4,682.00万2.12%250,000 150,000150.0% $2,809.20万 加仓
CYTK CYTOKINETICS INC $4,685.45万2.12%550,000 -150,483-21.5% -$1,281.96万 减仓
AVTX AVALO THERAPEUTICS INC $5,359.20万2.42%2,900,000 1,559,160116.3% $2,881.33万 加仓
ANAB ANAPTYSBIO INC $5,576.24万2.52%826,109 -113,891-12.1% -$768.76万 减仓
ORKA ORUKA THERAPEUTICS INC $5,615.03万2.54%590,000 90,32718.1% $859.64万 加仓
ALKS ALKERMES PLC $5,894.44万2.66%1,125,000 -225,000-16.7% -$1,178.89万 减仓
PRAX PRAXIS PRECISION MEDICINES I $6,193.61万2.80%185,000 15,0008.8% $502.19万 加仓
INSM INSMED INC $6,930.30万3.13%650,000 170,00035.4% $1,812.54万 加仓
ERAS ERASCA INC $9,618.00万4.35%5,250,000 -100,000-1.9% -$183.20万 减仓
XENE XENON PHARMACEUTICALS INC $9,627.42万4.35%1,595,000 -80,000-4.8% -$482.88万 减仓
SYRE SPYRE THERAPEUTICS INC $1.14亿5.13%1,279,134 00.0% — 不变
— APOGEE THERAPEUTICS INC $1.31亿5.92%987,000 -297,926-23.2% -$3,954.37万 减仓
ROIV ROIVANT SCIENCES LTD $1.33亿6.00%3,750,000 950,00033.9% $3,362.05万 加仓